Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
$16 Mln
Revenue (TTM)
$10 Mln
Net Profit (TTM)
$-21 Mln
ROE
-1.3 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
11.6
Industry P/E
--
EV/EBITDA
-3.4
Div. Yield
0 %
Debt to Equity
0
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
111,891,000
CFO
$-241.77 Mln
EBITDA
$-238.87 Mln
Net Profit
$-247.43 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Titan Medical (TMDI)
| -78.0 | 22.7 | -38.9 | -71.0 | -16.6 | -52.3 | -37.6 |
|
BSE Sensex*
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Titan Medical (TMDI)
| 4.8 | -63.2 | 245.5 | -59.4 | -86.3 | 25.0 | -68.0 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Titan Medical (TMDI)
|
0.1 | 16.1 | 10.0 | -3.6 | -384.7 | -21.2 | -- | 11.6 |
| 4.6 | 2,231.7 | 0.0 | -296.6 | -- | -- | -- | 25.7 |
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access... surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during surgical procedures. The company is headquartered in Toronto, Canada. Read more
CEO, Pres & Director
Mr. Cary G. Vance
CEO, Pres & Director
Mr. Cary G. Vance
Headquarters
Toronto, ON
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Titan Medical Inc (TMDI) is $0.15 (NASDAQ) as of 11-May-2023 09:30 EDT. Titan Medical Inc (TMDI) has given a return of -16.59% in the last 3 years.
Since, TTM earnings of Titan Medical Inc (TMDI) is negative, P/E ratio is not available.
The P/B ratio of Titan Medical Inc (TMDI) is 11.57 times as on 01-Jun-2023, a 388 premium to its peers’ median range of 2.37 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2021
|
--
|
--
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
|
2017
|
--
|
--
|
The 52-week high and low of Titan Medical Inc (TMDI) are Rs -- and Rs -- as of 03-Apr-2026.
Titan Medical Inc (TMDI) has a market capitalisation of $ 16 Mln as on 01-Jun-2023. As per SEBI classification, it is a company.
Before investing in Titan Medical Inc (TMDI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.00
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.